RIGI and bacterial meningitis: Together, these findings demonstrate that activation of cytosolic nucleic acid sensors, including RIG-I, with known agonists stimulate enhanced type I IFN responses and restriction of bacterial burden in glial cells, highlighting the potential to therapeutically employ such agonists during bacterial meningitis.